Birdwatch Archive

Birdwatch Note

2024-04-15 06:20:03 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

2021年11月に開催された予防接種・ワクチン分科会副反応検討部会において、 HPVワクチンの安全性について特段の懸念が認められないことが確認され、接種による有効性が副反応のリスクを明らかに上回ると認められました。 https://www.msdconnect.jp/products/gardasil-silgard9/column/hpvv-safty/ 同資料にて全国疫学調査(祖父江班)は ①HPVワクチン接種歴のない者においてもHPVワクチン接種後に報告されている症状と同様の「多様な症状」を呈する者が一定数存在 ②本調査によって、HPVワクチン接種と接種後に生じた症状との因果関係は言及できない と結論を出しました。 同資料に記載のNagoya studyでも同様の結論が出ています。

Written by 3DCD90AEC8AF5FFF7706305B4EC6970D218E177E146AEA9F70FD0A341B948DE7
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1779640658355261518

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1779756554918715404
  • noteId - 1779756554918715404
  • participantId -
  • noteAuthorParticipantId - 3DCD90AEC8AF5FFF7706305B4EC6970D218E177E146AEA9F70FD0A341B948DE7 Participant Details
  • createdAtMillis - 1713162003626
  • tweetId - 1779640658355261518
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 2021年11月に開催された予防接種・ワクチン分科会副反応検討部会において、 HPVワクチンの安全性について特段の懸念が認められないことが確認され、接種による有効性が副反応のリスクを明らかに上回ると認められました。 https://www.msdconnect.jp/products/gardasil-silgard9/column/hpvv-safty/ 同資料にて全国疫学調査(祖父江班)は ①HPVワクチン接種歴のない者においてもHPVワクチン接種後に報告されている症状と同様の「多様な症状」を呈する者が一定数存在 ②本調査によって、HPVワクチン接種と接種後に生じた症状との因果関係は言及できない と結論を出しました。 同資料に記載のNagoya studyでも同様の結論が出ています。

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-04-15 06:20:03 UTC
(1713162003626)
2024-04-15 12:33:00 UTC
(1713184380853)
CURRENTLY_RATED_HELPFUL 2024-04-16 03:20:25 UTC
(1713237625718)
CURRENTLY_RATED_HELPFUL 2024-04-15 12:33:00 UTC
(1713184380853)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-04-15 20:26:25 -0500 Rating Details
2024-04-15 16:44:27 -0500 Rating Details
2024-04-15 07:32:08 -0500 Rating Details
2024-04-15 06:56:46 -0500 Rating Details
2024-04-15 06:36:51 -0500 Rating Details
2024-04-15 06:12:37 -0500 Rating Details
2024-04-15 05:55:45 -0500 Rating Details
2024-04-15 04:55:07 -0500 Rating Details
2024-04-15 04:50:32 -0500 Rating Details
2024-04-15 04:49:12 -0500 Rating Details
2024-04-15 04:33:28 -0500 Rating Details
2024-04-15 04:28:16 -0500 Rating Details
2024-04-15 04:15:17 -0500 Rating Details
2024-04-15 04:13:44 -0500 Rating Details
2024-04-15 03:45:50 -0500 Rating Details
2024-04-15 03:35:57 -0500 Rating Details
2024-04-15 03:08:29 -0500 Rating Details
2024-04-15 03:02:52 -0500 Rating Details
2024-04-15 02:39:23 -0500 Rating Details
2024-04-15 02:32:05 -0500 Rating Details
2024-04-15 02:21:25 -0500 Rating Details
2024-04-15 02:09:53 -0500 Rating Details
2024-04-15 02:06:34 -0500 Rating Details
2024-04-15 01:45:58 -0500 Rating Details
2024-04-15 01:45:09 -0500 Rating Details
2024-04-16 00:01:56 -0500 Rating Details
2024-04-18 09:58:35 -0500 Rating Details
2024-04-17 17:37:10 -0500 Rating Details
2024-04-16 00:12:21 -0500 Rating Details
2024-04-15 17:20:00 -0500 Rating Details
2024-04-15 14:45:50 -0500 Rating Details
2024-04-15 10:22:54 -0500 Rating Details
2024-04-15 09:08:54 -0500 Rating Details
2024-04-15 07:53:49 -0500 Rating Details
2024-04-15 06:32:00 -0500 Rating Details
2024-04-15 05:07:53 -0500 Rating Details
2024-04-15 04:26:15 -0500 Rating Details
2024-04-15 04:07:40 -0500 Rating Details
2024-04-15 04:03:46 -0500 Rating Details
2024-04-15 03:52:16 -0500 Rating Details
2024-04-15 03:21:43 -0500 Rating Details
2024-04-15 03:08:47 -0500 Rating Details
2024-04-15 02:50:18 -0500 Rating Details
2024-04-15 02:48:05 -0500 Rating Details
2024-04-15 02:45:55 -0500 Rating Details
2024-04-15 02:41:05 -0500 Rating Details
2024-04-15 02:33:12 -0500 Rating Details
2024-04-15 02:29:16 -0500 Rating Details
2024-04-15 02:25:04 -0500 Rating Details
2024-04-15 02:10:14 -0500 Rating Details
2024-04-15 02:10:13 -0500 Rating Details
2024-04-15 02:08:34 -0500 Rating Details
2024-04-15 01:50:23 -0500 Rating Details
2024-04-15 01:41:09 -0500 Rating Details
2024-04-15 01:39:55 -0500 Rating Details
2024-04-20 03:24:39 -0500 Rating Details
2024-04-19 19:28:38 -0500 Rating Details
2024-04-18 21:57:07 -0500 Rating Details
2024-04-15 21:42:01 -0500 Rating Details
2024-04-15 17:28:06 -0500 Rating Details
2024-04-15 17:10:44 -0500 Rating Details
2024-04-15 09:42:36 -0500 Rating Details
2024-04-15 07:15:22 -0500 Rating Details
2024-04-15 05:57:25 -0500 Rating Details
2024-04-15 05:53:28 -0500 Rating Details
2024-04-15 04:59:57 -0500 Rating Details
2024-04-15 04:09:49 -0500 Rating Details
2024-04-15 03:59:07 -0500 Rating Details
2024-04-15 03:53:10 -0500 Rating Details
2024-04-15 03:43:21 -0500 Rating Details
2024-04-15 03:38:30 -0500 Rating Details
2024-04-15 03:06:06 -0500 Rating Details
2024-04-15 02:29:49 -0500 Rating Details
2024-04-15 02:29:34 -0500 Rating Details
2024-04-15 02:29:19 -0500 Rating Details
2024-04-15 02:24:44 -0500 Rating Details
2024-04-15 02:22:33 -0500 Rating Details
2024-04-15 02:12:55 -0500 Rating Details
2024-04-15 02:09:52 -0500 Rating Details
2024-04-15 02:09:41 -0500 Rating Details
2024-04-15 02:09:02 -0500 Rating Details
2024-04-15 02:02:13 -0500 Rating Details
2024-04-15 01:57:24 -0500 Rating Details
2024-04-15 01:57:21 -0500 Rating Details
2024-04-15 01:56:32 -0500 Rating Details
2024-04-15 01:54:47 -0500 Rating Details
2024-04-15 01:39:03 -0500 Rating Details
2024-04-15 17:38:37 -0500 Rating Details